Literature DB >> 1385958

Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma.

T Reblin1, D J Rader, U Beisiegel, H Greten, H B Brewer.   

Abstract

Lp(a) is an LDL-like lipoprotein which contains an additional apolipoprotein called apo(a). Apo(a) exhibits a significant size polymorphism and its size is inversely correlated with plasma Lp(a) levels. We investigated the distribution of different apo(a) isoproteins in lipoprotein density fractions. Fasting plasma samples were subjected to non-equilibrium density gradient ultracentrifugation. After SDS-PAGE and anti-apo(a) immunoblotting, apo(a) concentrations in individual density fractions were evaluated by densitometry. In series I, analysis of selected density fractions from 35 coronary heart disease (CHD) patients demonstrated that although most of the apo(a) was present in the Lp(a) density range, apo(a) was consistently found in both the VLDL and IDL fractions as well. In series II, density fractions from 9 normolipidemic subjects with 6 different apo(a) isoproteins were evaluated. A strong association between the size of the apo(a) isoprotein and the density of the associated Lp(a) particle was established (r = 0.976, P less than 0.001). Lp(a) densities ranged from 1.057 g/ml for the B isoprotein to 1.09 g/ml for the S5 isoprotein. Overall, 75% of the total apo(a) was detected in the Lp(a) density range (d = 1.05-1.12 g/ml), with 9% and 10% in the LDL (d = 1.019-1.05 g/ml) and HDL (d = 1.12-1.21 g/ml) fractions, respectively. VLDL contained an average of 4% of the total apo(a) in fasting normolipidemic plasma. Two hypertriglyceridemic subjects had substantially greater amounts of apo(a) in the fasting triglyceride-rich fraction. The results of this study indicate that the size of the apo(a) isoprotein strongly influences the density of its associated Lp(a) particle and that apo(a) is consistently found in the triglyceride-rich lipoproteins of fasting plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385958     DOI: 10.1016/0021-9150(92)90247-e

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity.

Authors:  Juan Guevara; Nagindra Prashad; Boris Ermolinsky; John W Gaubatz; Dongcheul Kang; Andrea E Schwarzbach; David S Loose; Natalia Valentinova Guevara
Journal:  J Lipid Res       Date:  2010-02-19       Impact factor: 5.922

2.  Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.

Authors:  Qibin Qi; Tsegaselassie Workalemahu; Cuilin Zhang; Frank B Hu; Lu Qi
Journal:  Eur Heart J       Date:  2011-09-06       Impact factor: 29.983

3.  A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.

Authors:  I Shai; M B Schulze; J E Manson; M J Stampfer; N Rifai; F B Hu
Journal:  Diabetologia       Date:  2005-06-22       Impact factor: 10.122

4.  A method for lipoprotein (a) Isolation from a small volume of plasma with applications for clinical research.

Authors:  Paul A Mueller; Elisabeth Yerkes; Paige Bergstrom; Sara Rosario; Joshua Hay; Nathalie Pamir
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

5.  The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.

Authors:  D J Rader; W Cain; K Ikewaki; G Talley; L A Zech; D Usher; H B Brewer
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.

Authors:  D J Rader; W Cain; L A Zech; D Usher; H B Brewer
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 7.  Lipoprotein(a): new insights into an atherogenic lipoprotein.

Authors:  W Bartens; C Wanner
Journal:  Clin Investig       Date:  1994-08

8.  The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

Authors:  D J Rader; W A Mann; W Cain; H G Kraft; D Usher; L A Zech; J M Hoeg; J Davignon; P Lupien; M Grossman
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.